Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nathan Y Yu

Showing results (21-30 of 109) with videos related to

Pageof 11
Sort By:
In Vivo (Athens, Greece)|October 31, 2023
Whole-breast Radiotherapy With Boost for Node-negative Breast Cancer: Conventional <i>vs</i>. Hypo-fractionationDirk Rades, Marie C Eggert, Stefan Janssen, et al.
Anticancer Research|April 28, 2025
Chemotherapy-induced Moderate to Severe Peripheral Neuropathy in Patients Receiving Adjuvant Radiotherapy for Breast CancerDirk Rades, Tobias Bartscht, Achim Rody, et al.
Rare Tumors|November 26, 2020
Radiotherapy for malignant melanoma of the lacrimal sacTiffany W Cheng, Nathan Y Yu, Mahesh Seetharam, et al.
Cancer Diagnosis & Prognosis|July 4, 2024
Prognostic Role of Platelet-to-Lymphocyte and Neutrophil-to-Lymphocyte Ratios in Patients Irradiated for Glioblastoma MultiformeOksana Zemskova, Nathan Y Yu, Anastassia Löser, et al.
In Vivo (Athens, Greece)|June 27, 2024
Evaluation of Five Prognostic Scores in Patients Receiving Chemoradiation for Primary Glioblastoma MultiformeOksana Zemskova, Nathan Y Yu, Anastassia Löser, et al.
Anticancer Research|August 30, 2023
Final Results of a Study Evaluating the Course of Distress Scores During Radiotherapy for Malignant DiseasesCansu Delikanli, Stefan Janssen, Søren Tvilsted, et al.
In Vivo (Athens, Greece)|August 26, 2024
Can Platelet-to-Lymphocyte Ratio (PLR) and Neutrophil-to-Lymphocyte Ratio (NLR) Help Predict Outcomes of Patients With Recurrent Glioblastoma?Oksana Zemskova, Nathan Y Yu, Jan Leppert, et al.
Cancer Diagnosis & Prognosis|September 6, 2023
Distress Scores During Radiotherapy for Lung Cancer: Course and Prognostic FactorsDirk Rades, Cansu Delikanli, Stefan Janssen, et al.
Biology|April 28, 2023
The First Survival Score for Patients Treated with Whole-Brain Radiotherapy Plus Simultaneous Integrated Boost for Brain MetastasesDirk Rades, Leonie Johannwerner, Elisa M Werner, et al.
Journal of the American Academy of Dermatology|October 8, 2019
Rational radiotherapy: The role in node-negative squamous cell carcinomaNathan Y Yu, Samir H Patel, Steven E Schild, et al.
Pageof 11

Showing results (21-30 of 109) with videos related to

Sort By:
Pageof 11
In Vivo (Athens, Greece)|October 31, 2023
Whole-breast Radiotherapy With Boost for Node-negative Breast Cancer: Conventional <i>vs</i>. Hypo-fractionationDirk Rades, Marie C Eggert, Stefan Janssen, et al.
Anticancer Research|April 28, 2025
Chemotherapy-induced Moderate to Severe Peripheral Neuropathy in Patients Receiving Adjuvant Radiotherapy for Breast CancerDirk Rades, Tobias Bartscht, Achim Rody, et al.
Rare Tumors|November 26, 2020
Radiotherapy for malignant melanoma of the lacrimal sacTiffany W Cheng, Nathan Y Yu, Mahesh Seetharam, et al.
Cancer Diagnosis & Prognosis|July 4, 2024
Prognostic Role of Platelet-to-Lymphocyte and Neutrophil-to-Lymphocyte Ratios in Patients Irradiated for Glioblastoma MultiformeOksana Zemskova, Nathan Y Yu, Anastassia Löser, et al.
In Vivo (Athens, Greece)|June 27, 2024
Evaluation of Five Prognostic Scores in Patients Receiving Chemoradiation for Primary Glioblastoma MultiformeOksana Zemskova, Nathan Y Yu, Anastassia Löser, et al.
Anticancer Research|August 30, 2023
Final Results of a Study Evaluating the Course of Distress Scores During Radiotherapy for Malignant DiseasesCansu Delikanli, Stefan Janssen, Søren Tvilsted, et al.
In Vivo (Athens, Greece)|August 26, 2024
Can Platelet-to-Lymphocyte Ratio (PLR) and Neutrophil-to-Lymphocyte Ratio (NLR) Help Predict Outcomes of Patients With Recurrent Glioblastoma?Oksana Zemskova, Nathan Y Yu, Jan Leppert, et al.
Cancer Diagnosis & Prognosis|September 6, 2023
Distress Scores During Radiotherapy for Lung Cancer: Course and Prognostic FactorsDirk Rades, Cansu Delikanli, Stefan Janssen, et al.
Biology|April 28, 2023
The First Survival Score for Patients Treated with Whole-Brain Radiotherapy Plus Simultaneous Integrated Boost for Brain MetastasesDirk Rades, Leonie Johannwerner, Elisa M Werner, et al.
Journal of the American Academy of Dermatology|October 8, 2019
Rational radiotherapy: The role in node-negative squamous cell carcinomaNathan Y Yu, Samir H Patel, Steven E Schild, et al.
Pageof 11